2022 Ljubljana, Slovenia

III-45 Amr Radwan
Design of a Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Dupilumab in Children Aged 1-11 Years, With Active Eosinophilic Esophagitis
Thursday 09:50-11:20